Two Stocks that were on trading halt today

trading halt

Orocobre Limited (ASX: ORE)

The stock of Lithium chemicals producer Orocobre Limited paused trading on stock exchange as the company requested ASX to place their securities in trading halt, pending the release of an announcement.

Having Lithium/Potash production and exploration operations in Argentina, the ASX listed Orocobre requested Australian Securities Exchange for trading halt from 4 September 2018 pending an announcement in relation to expected change in Argentina’s export taxes by the government.

ORE’s securities will remain in trading halt until the earlier of 6 September 2018 or the release of the announcement concerning change in export taxes. 

The last traded share price of Orocobre’s stock is $4.160. The stock has observed performance change of 6.83% over the past one year.

 

Sponsored ad by Kalkine

Syrah Resources Limited (ASX: SYR)

Syrah Resources Limited was at trading halt today, i.e. 4 September 2018.

Resource company Syrah Resources Limited requested ASX to place it securities in trading halt, pending completion of $94 million institutional placement.

On the same day, this resource company announced a fully underwritten $94 million institutional placement to complete the ramp up of the Balama Graphite Operation. After the completion of this placement, Australia and New Zealand’s eligible shareholders would be given the right by Syrah to participate in Share Purchase Plan (SPP). Balama contains a significant Vanadium Resource and is on track to achieve CY2018 production guidance of 135kt to 145kt, enabled by significant month on month production performance improvement.

The trading halt of SYR is expected to continue till 6 September 2018 or the release of company’s announcement relating the completion of the Placement, whichever falls earlier.

Syrah’s stock last traded at $2.460. There was a negative change of 16.09% in the last 12-months performance of the stock.

Dividend Stocks To Buy

The Income available from dividends remains attractive for many investors.

We take a look at the best yields on the market and assess what they say about a company’s prospect.

One Thing is certain, though, Australia interest rates are still low, making income difficult to come by and keeping the focus for many investors on high yielding stocks. Kalkine’s team of analysts bought you handpicked report for “Top 25 Dividend Stocks For 2018.”

ASX-relevant Special Reports are published year-round to provide a detailed analysis into an investing opportunity or a potential risk to your portfolio.

Click here to get your free report.


Disclaimer

The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. Kalkinemedia.com and associated websites are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). website), employees and/or associates of Kalkine Pty Ltd do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.

 

Join Our Discussion

Start discussion with value Investors for ASX Stock Market Investment and Opinion.


6 Cannabis Stocks under Investor’s Limelight…

Cannabis companies that sell both medicinal weed and recreational pot. Marijuana stocks to look at. Marijuana mergers and acquisitions. Dispensary data analytics. Upcoming marijuana IPO’s Those phrases have become increasingly common as marijuana legalization spreads.

Global spending on legal cannabis is expected to grow 230% to $32 billion in 2020 as compared to $9.5 in 2017, according to Arcview Market Research and BDS Analytics. As of June 29, 2018 the United States Marijuana Index, despite a lot of uncertainty around regulations, has over the past 1 year gained 71.49%, as compared to about 12% gain seen by the S&P 500.

Click here for your FREE Report

LEAVE A REPLY

Please enter your comment!
Please enter your name here